Published in Lab Invest on February 01, 1997
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry (1999) 1.29
B-FABP-expressing radial glial cells: the malignant glioma cell of origin? Neoplasia (2007) 1.04
Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. Am J Pathol (1997) 0.88
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis. PLoS One (2013) 0.79
Familial glioblastoma: A case report of glioblastoma in two brothers and review of literature. Surg Neurol Int (2011) 0.77
Perinatal (fetal and neonatal) astrocytoma: a review. Childs Nerv Syst (2016) 0.75
Congenital gemistocytic astrocytoma in a fetus. Childs Nerv Syst (2005) 0.75
Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol (1999) 4.25
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
Left-right asymmetry and kinesin superfamily protein KIF3A: new insights in determination of laterality and mesoderm induction by kif3A-/- mice analysis. J Cell Biol (1999) 3.14
Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol (1997) 2.40
Hans-Joachim Scherer (1906-1945), pioneer in glioma research. Brain Pathol (1999) 2.20
A detachable balloon procedure for a traumatic internal carotid-internal jugular fistula: report of a case. Neurosurgery (1990) 2.10
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol (1986) 2.07
Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci (1996) 1.91
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1985) 1.76
Carcinogenicity of N-methyl-N-nitrosourea: possible role of excision repair of O6-methylguanine from DNA. J Natl Cancer Inst (1974) 1.76
Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component. Acta Neuropathol (1991) 1.72
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis (2001) 1.71
Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res (1997) 1.71
Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol (1999) 1.66
A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol (1990) 1.64
Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab Invest (2000) 1.59
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res (2001) 1.58
Genetic profile of gliosarcomas. Am J Pathol (2000) 1.57
Near-real-time guidance using intraoperative magnetic resonance imaging for radical evacuation of hypertensive hematomas in the basal ganglia. Neurosurgery (2000) 1.57
Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol (1993) 1.57
Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest (2001) 1.54
Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol (1999) 1.54
PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol (1998) 1.52
Reversibility of ischemic brain damage. Arch Neurol (1973) 1.48
Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci (2000) 1.48
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res (1992) 1.48
Dynamic changes during evacuation of a left temporal abscess in open MRI: technical case report. Neuroradiology (2002) 1.45
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest (1994) 1.45
p53 mutations in nonastrocytic human brain tumors. Cancer Res (1991) 1.42
Intracranial dermoid cysts: variations of radiological and clinical features. Acta Neurochir (Wien) (2008) 1.41
APC mutations in sporadic medulloblastomas. Am J Pathol (2000) 1.40
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg (1988) 1.40
Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol (1993) 1.39
More about: cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (2000) 1.39
Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol (1990) 1.38
Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg (1992) 1.36
Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neuropathol (1986) 1.35
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res (2000) 1.35
Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog (1993) 1.32
Cerebellar hemorrhage after supratentorial craniotomy--report of three cases. Neurol Med Chir (Tokyo) (1990) 1.31
Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res (1998) 1.29
Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (1989) 1.27
p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol (2001) 1.27
Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gan (1984) 1.26
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene (2003) 1.26
Results of microsurgical extra-intracranial arterial bypass in the treatment of cerebral ischemia. Neurosurgery (1978) 1.25
Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis (1984) 1.24
Intraoperative validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex. J Neurosurg (1999) 1.24
Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N-nitrosourea. Biochem J (1975) 1.24
Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) (1992) 1.24
Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res (1989) 1.23
Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol (1995) 1.23
The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery (1996) 1.20
Transvenous embolization of dural caroticocavernous fistulae: technical considerations. Neuroradiology (1993) 1.20
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol (1997) 1.19
Neuroimaging of cerebellar liponeurocytoma. Case report. J Neurosurg (2001) 1.19
Differentiation in the medulloblastoma. A histological and immunohistochemical study. Acta Neuropathol (1987) 1.19
Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol (1997) 1.19
Human islet isolation for autologous transplantation: comparison of yield and function using SERVA/Nordmark versus Roche enzymes. Am J Transplant (2009) 1.18
Evaluation of islet transplantation from non-heart beating donors. Am J Transplant (2006) 1.18
Growth rate of human pituitary adenomas. J Neurosurg (1987) 1.17
Atypical central neurocytoma. J Neuropathol Exp Neurol (1997) 1.17
Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien) (2003) 1.15
O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J Neurosurg (1989) 1.15
[Morphology and growth of tumors of the nervous system produced transplacentally by ethylnitroso-urea]. Verh Dtsch Ges Pathol (1968) 1.15
Purine nucleotide metabolism in the cat brain after one hour of complete ischemia. J Neurochem (1974) 1.14
Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol (1997) 1.14